Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Thei… (NCT04090619) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
United States192 participantsStarted 2021-06-22
Plain-language summary
This trial studies the frequency of cachexia in ambulatory cancer patients and the psychological burden in patients and their primary caregivers who are referred to an outpatient supportive care clinic. Studying how often loss of appetite and/or unintentional weight loss (cachexia) occurs in patients seen in the supportive care clinic may help researchers develop new ways to lower stress in patients who suffer from loss of appetite and weight loss as well as their family caregivers.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. \[Patient\] Patients visiting the Supportive Care Clinic (SCC) for a consultation or a follow up.
. \[Patient\] Patients who can identify a primary caregiver.
. \[Patient\] Diagnosis of advanced cancer defined as locally advanced, recurrent, or metastatic.
. \[Patient\] Be able to read and speak English.
. \[Patient\] 18 years of age or older.
. \[Caregiver\] Be identified or self-identified as a primary caregiver of the patient.
. \[Caregiver\] Provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
. \[Caregiver\] Be able to read and speak English.
Exclusion criteria
. \[Patient\] Refusal to participate in this study. This study requires both patient and caregiver enrollment.
. \[Patient\] Patients with no caregiver or only paid caregivers.
. \[Patient\] Patients with cognitive impairment as identified by research staff, treating physician or nurse (Memorial Delirium Assessment Scale score of \>/= 7).
. \[Caregiver\] Refusal to participate in this study. This study requires both patient and caregiver enrollment.
. \[Caregiver\] Not a primary caregiver or is a paid caregiver.
. \[Caregiver\] Evidence of cognitive impairment, as determined based on orientation questions pertaining to the date, day of the week, time, and place